TCM
CELG

Tuttle Capital Management’s Celgene Corp CELG Stock Holding History

Tuttle Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-27,089
Closed -$2.56M – 212
2019
Q1 		$2.56M Buy
+27,089
New +$2.37M 0.51% 63

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Tuttle Capital Management's CELG Position: Q2 2019 in Review

Tuttle Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 27,089 shares — an estimated $2.56M sold.

Tuttle Capital Management first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $2.56M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Tuttle Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Tuttle Capital Management sold 27,089 Celgene Corp shares in Q2 2019, an estimated $2.56M.
  • Tuttle Capital Management first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
  • Tuttle Capital Management's Celgene Corp position peaked at $2.56M in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Tuttle Capital Management's 13F filing for Q2 2019, filed 29 Jul 2019.